Wilson Sonsini is proud to sponsor DHNY. On Wednesday, September 18 at 8:15 a.m., partners Megan Baier and Maneesha Mithal will join industry leaders in a panel discussion exploring the impact of the 2024 election on key regulatory areas and implications for Private Equity (PE) and Venture Capital (VC) backed digital health companies.
Election 2024: Emerging Regulatory Trends in the Digital Health Sector
This discussion will explore the impact of the 2024 election on key regulatory areas and implications for Private Equity (PE) and Venture Capital (VC) backed digital health companies. We’ll provide crucial perspectives on topics including: the anticipated effects of increased oversight of PE and VC investments in health care; alignment of privacy and security laws to modern data sharing and technology; and regulating the use of AI in healthcare.
Shelly Jackson
shelly.jackson@wsgr.com
Megan Baier is chief executive officer of Wilson Sonsini and a member of the firm’s board of directors. As CEO, she is responsible for firm strategy, culture, and talent, and leads the day-to-day management of the firm’s business performance, including its operations, financial results, growth, AI and innovation, and risk management.
Megan has spent her career advising founders, boards, and public companies through the moments that define them: first financings, public offerings, and the governance decisions that follow. As a member of Wilson Sonsini's New York corporate group, she combines deep technical command of securities law with the judgment and steadiness clients need when the stakes are high.
A partner in the Washington, D.C., office of Wilson Sonsini and co-chair of the firm's data, privacy and cybersecurity practice, Maneesha Mithal advises clients on a range of privacy, AI, and consumer protection issues. Drawing on her tenure at the FTC's Bureau of Consumer Protection, she represents clients in FTC and state AG investigations involving privacy, AI, advertising and marketing compliance, endorsements and reviews, subscription practices, minor safety, and other unfair and deceptive practices (UDAP) matters.